Head and Neck Cancer: Key Challenges and Emerging Opportunities

CME-Certified Interactive Virtual Presentation:

Recent Advances in the Treatment of Head and Neck Cancer In this Interactive Virtual Presentation, Corey J. Langer MD, FACP, leads participants through a case-based review of the latest data on optimal treatment strategies for patients with newly diagnosed and recurrent/metastatic head and neck cancer.

This downloadable slideset provides a case-based review of the latest data on optimal treatment strategies for patients with newly diagnosed and recurrent/metastatic head and neck cancer. Click here to download slides.

Informed Decisions: Helping Patients Understand the Choice Regarding Anthracyclines in the Adjuvant Treatment of Breast Cancer 

In this Interactive Virtual Presentation, Peter Ravdin, MD, PhD, discusses the differences between anthracycline and nonanthracycline chemotherapy regimens and how to best communicate these differences in treatment choices to patients with breast cancer.

CME-Certified Interactive Virtual Presentation:

Talking With a Patient About Anthracycline- vs Nonanthracycline-Based Chemotherapy Peter Ravdin, MD, PhD, discusses the differences between anthracycline and nonanthracycline chemotherapy regimens and how to best communicate these differences in treatment choices to patients with breast cancer.

Downloadable slideset on the differences between anthracycline and nonanthracycline chemotherapy regimens and how to best communicate these differences in treatment choices to patients with breast cancer. Click here to download slides.

A Call to Action: Emerging Strategies to Optimize Bone Health in Breast Cancer

In this CME-certified slideset module, Michael Gnant, MD; Allan Lipton, MD; and Gregory R. Mundy, MD, provide an overview of the molecular mechanisms involved in cancer-related bone disease and summarize the latest data on new therapies for preventing cancer treatment–induced bone loss and skeletal-related events in breast cancer patients.

CME-Certified Slideset Module:

A Call to Action: Emerging Strategies to Optimize Bone Health in Breast Cancer Michael Gnant, MD; Allan Lipton, MD; and Gregory R. Mundy, MD, provide an overview of the molecular mechanisms involved in cancer-related bone disease and summarize the latest data on new therapies for preventing cancer treatment–induced bone loss and skeletal-related events in breast cancer patients.

Downloadable PowerPoint Slideset:

A Call to Action: Emerging Strategies to Optimize Bone Health in Breast Cancer Downloadable slideset including an overview of the molecular mechanisms of cancer-related bone disease and the latest data on new therapies for preventing cancer treatment–induced bone loss and skeletal-related events in breast cancer patients.

Clinical Advances in Colorectal Cancer: The Role of Targeted Therapy in the Continuum of Care

CME-Certified Interactive Virtual Presentation:

Toward Individualized Therapies: Metastatic Colorectal Cancer Alan P. Venook, MD, explores the future of individualized treatment in patients with colorectal cancer, with a focus on predictive biomarkers.

Download slides reviewing the prospect of individualized treatment in patients with colorectal cancer. Click here to download slides.

2009 American Society of Hematology Annual Meeting

CCO's independent Conference Coverage of the 2009 Hematology meeting includes Capsule Summaries of key presentations, as well as Expert Analyses, Downloadable Slides, and audio Expert Highlights that focus on key issues highlighted at the conference.

Acute Myelogenous Leukemia/Acute Lymphoblastic Leukemia
Dan Douer, MD; Hagop M. Kantarjian, MD; and  Martin S. Tallman, MD

Chronic Lymphocytic Leukemia
Susan M. O’Brien, MD and Kanti Rai, MD

Chronic Myelogenous Leukemia
Brian Druker, MD; Neil P. Shah, MD, PhD; and Moshe Talpaz, MD

Idiopathic Thrombocytopenic Purpura
Howard Liebman, MD and Keith McCrae, MD

Lymphomas
James O. Armitage, MD; Richard I. Fisher, MD; and Andre Goy, MD, MPH

Myelodysplastic Syndromes
Alan F. List, MD; Azra Raza, MD; and  Lewis Silverman, MD

Multiple Myeloma
Kenneth Anderson, MD; Sagar Lonial, MD; and Paul G. Richardson, MD

CME-Certified Expert Analyses:

Lymphomas In this Expert Analysis, renowned faculty members discuss results from several studies presented at the 2009 American Society of Hematology Annual Meeting that evaluate new treatment approaches in lymphomas.

Myelodysplastic Syndromes Alan F. List, MD; Azra Raza, MD; Bart L. Scott, MD, MS; and Lewis Silverman, MD, discuss studies presented at the 2009 Hematology meeting on myelodysplastic syndromes, with a focus on new approaches for patients with high-risk disease and those with disease refractory to hypomethylating agents.

Chronic Lymphocytic Leukemia Susan M. O’Brien, MD, and Kanti Rai, MD, review the most important data in the setting of chronic lymphocytic leukemia reported at the 2009 American Society of Hematology Annual Meeting.

Immune Thrombocytopenic Purpura Howard Liebman, MD, and Keith R. McCrae, MD, review and provide their clinical prospective on several important immune thrombocytopenia abstracts presented at the 2009 American Society of Hematology Annual Meeting.

Downloadable PowerPoint Slidesets:

Lymphomas Download slides on the most compelling data in lymphoma presented at the 2009 Hematology Annual Meeting. Click here to download slides.

Advances in Myeloma Review highlights of the most clinically relevant studies in multiple myeloma presented at the 2009 Hematology meeting. Click here to download slides.

Acute Leukemias and Myelodysplastic Syndromes Hagop Kantarjian MD, provides a slideset summary of the most notable studies in ALL, AML, and MDS presented at the 2009 Hematology Annual Meeting. Click here to download slides.

2009 Annual Meeting of the AACR-CTRC San Antonio Breast Cancer Symposium

CCO's independent coverage of the 2009 Annual Meeting of the AACR-CTRC San Antonio Breast Cancer Symposium includes Capsule Summaries of key presentations, as well as Expert Analyses, Slides, and audio Expert Highlights that focus on key issues highlighted at the conference.

Early Breast Cancer
Harold J. Burstein, MD, PhD; Peter Ravdin, MD, PhD; Nicholas J. Robert, MD; Jeffrey Smerage, MD, PhD Moderator

Metastatic Breast Cancer
Clifford A. Hudis, MD; Kathy D. Miller, MD; George W. Sledge, Jr., MD; Frankie Holmes, MD, FACP Moderator

Prognosis and Prediction
Paul E. Goss, MD, PhD, FRCPC, FRCP; William J. Gradishar, MD, FACP; Daniel F. Hayes, MD; Robert A. Mocharnuk, MD Moderator

CME-Certified Expert Analyses:

Early Breast Cancer Harold J. Burstein, MD, PhD; Peter Ravdin, MD, PhD; Nicholas J. Robert, MD; and Jeffrey B. Smerage, MD, PhD, review and discuss the most pertinent new data and research on early breast cancer presented at the 2009 San Antonio Breast Cancer Symposium.

Metastatic Breast Cancer Frankie Ann Holmes, MD, FACP; Clifford A. Hudis, MD; Kathy D. Miller, MD; and George W. Sledge, Jr., MD, discuss the most clinically relevant results in the setting of metastatic breast cancer presented at the 2009 Breast Cancer Symposium.

Breast Cancer: Prognosis and Prediction Paul E. Goss, MD, PhD, FRCPC, FRCP; William J. Gradishar, MD, FACP; Daniel F. Hayes, MD; and Robert S. Mocharnuk, MD, review and discuss several of the most significant abstracts pertaining to prediction and prognosis factors in the setting of breast cancer that were presented at the 2009 Breast Cancer Symposium.

Downloadable PowerPoint Slidesets:

Early Breast Cancer: Highlights Download slides on the most clinically-relevant data in early breast cancer presented at the 2009 Breast Cancer Annual meeting.

Metastatic Breast Cancer: Highlights Review highlights of clinically relevant studies in metastatic breast cancer presented at the 2009 Breast Cancer Annual Meeting.

Spanning the Continuum of Care: Optimizing Patient Outcomes in Multiple Myeloma

CCO’s expert faculty members review current thinking regarding the optimal treatment of multiple myeloma, including survival gains, transplantation, and novel agents.

CME-Certified Modules:

Relapsed/Refractory Multiple Myeloma: Options for Subsequent Therapy Amitabha Mazumder, MD, reviews the management approach to relapsed or refractory disease, highlighting the role for novel therapies and the need for supportive care, while also considering the potential for future drug development.

Frontline Treatment of Multiple Myeloma: Current Options for Initial Therapy (coming soon)

Multiple Myeloma: Treatment Options for Special Patient Populations (coming soon)

Navigating the Therapeutic Pathways for AML and MDS 

Through 4 Virtual Presentations and downloadable slidesets, CCO’s expert faculty members explore the current state-of-the-art AML and MDS treatments. Topics include the role of risk stratification in treatment decision making, outcomes for various therapeutic options such as chemotherapy and transplantation, the latest information on clinical trials, and special clinical issues in AML and MDS such as refractory disease and the role of novel molecular diagnostics. This program is produced in partnership with the National Marrow Donor Program® (NMDP). The NMDP facilitates unrelated donor transplantations, conducts research, provides medical education, and supports patients.

CME-Certified Virtual Presentations:

Incorporating Molecular Data Into Risk Stratification for AML Steven M. Devine, MD, provides up-to-date information on risk stratification in patients with AML and discusses how data on karyotyping, molecular markers, and age affect treatment choices.

Download a slideset in which Steven Devine, MD, provides up-to-date information on risk stratification in patients with AML, and discusses how this affects treatment choices. Click here to download slides.

The Role of Allogeneic Hematopoietic Cell Transplantation in AML Frederick R. Appelbaum, MD, explores the changes that have improved outcomes of allogeneic transplantation in patients with acute myeloid leukemia.

Download a slideset in which Frederick Appelbaum, MD, explores the changes improved outcomes of allogeneic transplantation in patients with acute myeloid leukemia. Click here to download slides.

Options for High-Risk Acute Myeloid Leukemia and Myelodysplastic Syndromes Daniel Weisdorf, MD, provides an overview of the considerations for allogeneic transplantation in patients with high-risk AML or those with MDS.

Download a slideset in which Daniel Weisdorf, MD, provides an overview of considerations for allogeneic transplantation in patients with high-risk AML or those with MDS. Click here to download slides.

Advances in AML/MDS: The Role of Multicenter Clinical Trials Dennis L. Confer, MD, highlights the essential role of multicenter clinical trials in expanding transplantation access and identifying optimal treatment approaches for patients with AML and MDS, including studies available through the Blood and Marrow Transplant Clinical Trials Network.

Download a slideset in which Dennis L. Confer, MD, highlights the essential role of multicenter clinical trials in expanding transplantation access and identifying optimal treatment approaches for patients with AML and MDS. Click here to download slides.

Spanning the Spectrum of Care: Clinical Advances and Practical Applications in Lymphoma 

CCO’s expert faculty members explore current and emerging treatment options and approaches for the clinical management of patients with lymphomas, including mantle cell lymphoma, follicular lymphoma, T-cell lymphoma, DLBCL, and Waldenström’s macroglobulinemia.

CME-Certified Modules:

Mechanisms of Action and Clinical Advances in the Treatment of Non-Hodgkin’s Lymphomas Deborah A. Frieze, PharmD, BCOP, and Alice Mohr, RN, MSN, FNP-BC, provide a broad overview of standard and emerging agents and approaches for the treatment of non-Hodgkin’s lymphomas.

Clinical Considerations and Implications for Optimizing Outcomes in Patients With NHL Alice Mohr, RN, MSN, FNP-BC, and Deborah A. Frieze, PharmD, BCOP, review dosing regimens, critical safety issues, appropriate preventive care, and supportive care measures associated with the use of various therapeutic modalities for the treatment of non-Hodgkin’s lymphoma.

CME-Certified Interactive Virtual Presentations:

Evolving Options and Challenges in Mantle Cell Lymphoma Listen to a virtual presentation by Andre Goy, MD, as he provides a comprehensive overview of evolving treatment options for patients with mantle cell lymphoma, and test your knowledge of treatment options in the cases he presents.

Evolving Options and Challenges in Mantle Cell Lymphoma Downloadable slideset on the standards of care and emerging novel therapies for the treatment of mantle cell lymphoma

Indolent B-Cell Disorders: Follicular Lymphoma and Waldenström’s Macroglobulinemia Downloadable slideset on the standards of care and emerging novel therapies for the treatment of follicular lymphoma and Waldenström’s Macroglobulinemia.

Therapeutic Approaches in T-Cell Lymphomas: PTCL and CTCL Downloadable slideset on the standards of care and emerging novel therapies for the treatment of T-Cell lymphomas.

Clinical Considerations and Strategies for Managing Patients With DLBCL Downloadable slideset on the standards of care and emerging novel therapies for the treatment of diffuse large B-cell lymphoma.

CCO Downloadable Slideset:

Overview of Treatment Options and Clinical Considerations for Managing NHL Patients Review a comprehensive overview of current standards of care for lymphoma, including nursing considerations, such as dosing schedules, adverse effects, and improving patient quality of life.

Novel Developments in the Treatment of Malignant Mesothelioma 

CME-Certified Module:

Novel Developments in the Treatment of Malignant Mesothelioma Marcelo C. DaSilva, MD, FACS, FCCP, and David J. Sugarbaker, MD, provide an in-depth review of the latest developments in the clinical management of patients with malignant mesothelioma.

CME-Certified Interactive Virtual Presentations:

Contemporary Management of Malignant Pleural Mesothelioma Nicholas J. Vogelzang, MD, provides an overview of current diagnostic and treatment approaches for patients with malignant pleural mesothelioma.

Nicholas J. Vogelzang, MD, reviews current data that suggest new ways of treatment for this previously difficult-to-treat disease. Click here to download slides.

Treatment Update on T-Cell Lymphoma

Listen to expert faculty members discuss the latest data and present compelling cases in 2 new Interactive Virtual Presentations and read a comprehensive text-based module focused on clinical advancements for the treatment of T-cell lymphoma, including PTCL and CTCL.

CME-Certified Module:

Recent Clinical Advances and Research Developments in T-Cell Lymphomas Owen A. O'Connor, MD, PhD, provides a comprehensive overview on standard and emerging agents and approaches for the treatment of T-cell lymphomas.

CME-Certified Interactive Virtual Presentations:

Current and Emerging Treatment Options for Patients With Peripheral T-Cell Lymphoma Steven M. Horwitz, MD, discusses current and emerging treatment options for patients with peripheral T-cell lymphoma.

Downloadable slideset on the standards of care and emerging novel therapies for the treatment of peripheral T-cell lymphoma.

Current and Emerging Treatment Options in Cutaneous T-Cell Lymphoma John A. Zic, MD, discusses the pathogenesis, staging, and treatment options for patients with cutaneous T-cell lymphoma.

Downloadable slideset on the standards of care and emerging novel therapies for the treatment of cutaneous T-cell lymphoma.

Idiopathic Thrombocytopenic Purpura (ITP): Shifting the Treatment Paradigm

Explore recent findings regarding idiopathic thrombocytopenic purpura (ITP) through a video module and 6 downloadable slidesets. Topics include ITP etiology, pathophysiology, and review of recent data and expert recommendations on corticosteroids, immunotherapy, and other novel treatment strategies.

CME-Certified Video Module:

Idiopathic Thrombocytopenic Purpura: Shifting the Treatment Paradigm In this CME-certified video, Howard Liebman, MD, provides a comprehensive overview of the pathology and treatment of immune thrombocytopenia.

Downloadable PowerPoint Slidesets:

Pathophysiology of ITP This downloadable slideset provides a pathology overview of primary and secondary immune thrombocytopenia.

Standard Drug Treatments for Primary Immune Thrombocytopenia This downloadable slideset provides an overview of standard treatment options for patients with immune thrombocytopenia.

Advances in Immunotherapy Approaches to ITP This downloadable slideset provides an overview of high-dose dexamethasone, rituximab, veltuzumab therapies for immune thrombocytopenia.

Targeting Growth Factors for the Management of ITP This downloadable slideset gives an overview of the rationale for the targeting of the thrombopoietin receptor and the clinical application of this approach in ITP.

Bringing It All Together: Guidelines & Expert Recommendations Based on Diagnostic & Treatment Advances This downloadable slideset provides an overview of recently published treatment recommendations for patients with immune thrombocytopenia.

Future Therapy for ITP: What’s Next? This downloadable slideset provides insights into research directions in ITP.

Practice in Evolution: Optimal Management of NSCLC 

This new CME/CE-certified Treatment Update includes journal article reviews, case discussion, video, and downloadable slidesets presenting the latest data in non-small-cell lung cancer treatment.

Now Available!

Journal Article Reviews:

CME-Certified Module:

Cases Cubed: 3 Cases, 3 Expert Opinions in Non-Small-Cell Lung Cancer Roy S. Herbst, MD, PhD; Vincent A. Miller, MD; and Alan B. Sandler, MD, present and discuss 3 case studies highlighting the factors that go into making challenging non-small-lung cancer treatment decisions, with particular consideration of biomarker analysis, use of adjuvant therapy, and maintenance therapy.

Downloadable PowerPoint Slidesets:

Selected Currently Enrolling Phase III Clinical Trials in NSCLC Download PowerPoint slides highlighting the key features of a selection of the largest active multicenter phase III trials in NSCLC.

CME-Certified Video Module:

Practice in Evolution: Recent Advances in the Treatment of NSCLC Roy S. Herbst, MD, PhD, discusses the clinical implications of recently published or presented data on the treatment of non-small-cell lung cancer.

Evolutions in VEGF-Targeted Therapy for GBM: Recent Advances and Ongoing Research

Through a CME-certified didactic text module and 3 Interactive Virtual Presentations, CCO’s expert faculty members explore new thinking and recent findings regarding anti-VEGF strategies in the treatment of glioblastoma.


CME-Certified Module:
The Changing Landscape of Glioblastoma Multiforme

James J. Vredenburgh, MD, reviews the biology of glioblastomas and discusses currently available and investigational anti-VEGF therapies for this disease. Click here to begin.

CME-Certified Interactive Virtual Presentations:
Expanding Treatment Options for Glioblastoma: Past, Present, and Future

In this case-based Interactive Virtual Presentation, Timothy Cloughesy, MD, discusses current data in current treatment modalities for patients with glioblastoma. Click here to begin.

Expanding Treatment Options for Glioblastoma: Past, Present, and Future

Download slides on the most recurrent data in glioblastoma therapies. Click here to download slides.

Optimizing Patient Outcomes With Angiogenic Inhibitors for the Treatment of GBM

Laurie Rice, RN, MSN, NP, highlights optimal strategies for preventing and coping with potential adverse events during antiangiogenesis therapy for glioblastoma. Click here to begin.

Optimizing Patient Outcomes With Angiogenic Inhibitors for the Treatment of GBM

Laurie Rice, RN, MSN, NP, provides an overview of monitoring and management strategies for adverse events associated with antiangiogenesis therapy in patients with glioblastoma. Click here to download slides.

Disrupting the Cell Cycle: Microtubule-Targeted Therapies in Metastatic Breast Cancer

This slideset, presented at a CCO satellite symposium in San Antonio, Texas, reviews important clinical data in microtubule-targeted therapies in metastatic breast cancer.

Downloadable PowerPoint Slideset: Disrupting the Cell Cycle: Microtubule-Targeted Therapies in Metastatic Breast Cancer Downloadable slides on the role of microtubule-targeted therapies in metastatic breast cancer.

Evolving Treatment Paradigms for GIST: Current Approaches and Agents on the Horizon

In this CME-certified Treatment Update, Ricardo J. Gonzalez, MD, and Jonathan C. Trent, MD, PhD, explore changes in treatment of gastrointestinal stromal tumors.

CME-Certified Module:

Gastrointestinal Stromal Tumors Ricardo J. Gonzalez, MD, explores the biology of gastrointestinal tumors, the currently available treatment options, and the novel agents under investigation for this disease.

Coming Soon!

Interactive Virtual Presentation:

Application of Novel Approaches to Treatment of Chronic Immune (Idiopathic)Thrombocytopenia

This CME-certified educational program provides an overview of the diagnosis and pathology of immune thrombocytopenia as well as discussion of evolving treatment approaches by expert faculty members James B. Bussel, MD, and Keith R. McCrae, MD.

Now Available!

CME-Certified Module:
Advances in the Management of Patients With Immune Thrombocytopenia

James B. Bussel, MD reviews the pathology, diagnosis, and treatment of immune thrombocytopenia. Click here to begin.

Keith R. McCrae, MD, provides an overview of the diagnosis and pathology of immune thrombocytopenia (ITP) then discusses eveloving treatment approaches for the management of ITP. Click here to begin.

Downloadable PowerPoint Slideset:

This downloadable slideset provides an overview of immune thrombocytopenia including pathology and diagnosis with case scenarios highlighting optimal management strategies for patients with primary immune thrombocytopenia. Click here to download slides.

Myelodysplastic Syndromes: Integrating Novel Agents Into Current Treatment Algorithms 

Review a comprehensive text-based module on recent advances in the diagnosis, classification, and treatment of MDS; use the interactive MDS tool to help guide treatment choices tailored to your specific patient.

CME-Certified Module:

Understanding Myelodysplastic Syndromes: Diagnosis, Classification, and Treatment Naomi Galili, PhD, and Azra Raza, MD, discuss recent advances in the diagnosis, classification, and treatment of MDS.

Interactive Decision Support Tool:

Treatment Recommendations for Patients With Myelodysplastic Syndrome This interactive decision support tool is designed to determine optimal treatment recommendations for a patient with myelodysplastic syndrome based on treatment guidelines and expert faculty input.

Novel Therapeutic Research and Priority Trials in Breast Cancer: An Online Clinical Management Series 

This new CME-certified Treatment Update, produced in collaboration with the Coalition of Cancer Cooperative Groups, includes a Virtual Presentation, downloadable slideset, and white paper reviewing high-priority research areas and clinical trials in breast cancer.

Now Available!

CME-Certified Virtual Presentation:

SLC Consensus on Research Priorities in Breast Cancer In this Interactive Virtual Presentation, Edith A. Perez, MD, reviews high-priority research areas and clinical trials in breast cancer, as identified by the Breast Cancer Scientific Leadership Council.

Downloadable PowerPoint Slideset:

SLC Consensus on Research Priorities in Breast Cancer: Meeting Overview Downloadable slideset which reviews the high-priority research areas and clinical trials in breast cancer, as identified by the Breast Cancer Scientific Leadership Council. Click here to download slides.

Downloadable White Paper:

Research Priorities in Breast Cancer: Recommendations of the Scientific Leadership Council in Breast Cancer of the Coalition of Cancer Cooperative Groups Download PDF of white paper produced on recommendations of the SLC in Breast Cancer as presented at the Coalition of Cancer Cooperative Groups meeting in September 2008. Click here to download worksheet.

Idiopathic Thrombocytopenic Purpura (ITP): Shifting the Treatment Paradigm

Explore recent findings on immune thrombocytopenia (ITP) through a video module* and 6 downloadable slidesets. Topics include ITP etiology, pathophysiology, standard and new treatment strategies, recent expert recommendations, and future directions.

Downloadable PowerPoint Slidesets:

Pathophysiology of ITP This downloadable slideset provides a pathology overview of primary and secondary immune thrombocytopenia. Click here to download slides.

Standard Drug Treatments for Primary Immune Thrombocytopenia This downloadable slideset provides an overview of standard treatment options for patients with immune thrombocytopenia. Click here to download slides.

Advances in Immunotherapy Approaches to ITP This downloadable slideset provides an overview of high-dose dexamethasone, rituximab, veltuzumab therapies for immune thrombocytopenia. Click here to download slides.

Targeting Growth Factors for the Management of ITP This downloadable slideset gives an overview of the rationale for the targeting of the thrombopoietin receptor and the clinical application of this approach in ITP. Click here to download slides.

Bringing It All Together: Guidelines & Expert Recommendations Based on Diagnostic & Treatment Advances This downloadable slideset provides an overview of recently published treatment recommendations for patients with immune thrombocytopenia. Click here to download slides.

Future Therapy for ITP: What’s Next? This downloadable slideset provides insights into research directions in ITP. Click here to download slides.

Coming Soon!

CME-Certified Video Module:

Overview of the Causes and Treatments for ITP

Joint 15th Congress of the European CanCer Organisation (ECCO) and 34th Congress of the European Society for Medical Oncology (ESMO)

Join CCO’s expert faculty members as they review the clinical implications of research on gastrointestinal, genitourinary, breast, and lung cancers presented at the 2009 ECCO/ESMO Congress.

CME-Certified Conference Reports:
Breast and Lung Cancers

Gunter von Minckwitz, MD, PhD, and Giuseppe Giaccone, MD, PhD, discuss the most clinically relevant abstracts on lung cancer and breast cancer presented at the joint 15th Congress of the European CanCer Organisation (ECCO) and 34th Congress of the European Society for Medical Oncology (ESMO). Click here to begin.

Gastrointestinal and Genitourinary Cancers

Josep Tabernero, MD, and Bernard Escudier, MD, discuss the most clinically relevant abstracts on gastrointestinal cancer and genitourinary cancer presented at the joint 15th Congress of the European CanCer Organisation (ECCO) and 34th Congress of the European Society for Medical Oncology (ESMO). Click here to begin.

A Call to Action for Hematology Fellows: Clinical Advances and Patient Considerations in Lymphomas

Through a didactic module, an Interactive Virtual Presentation, and a downloadable slideset, explore current optimal treatment strategies for non-Hodgkin’s lymphomas.

CME-Certified Module:

CME-Certified Interactive Virtual Presentation:

Downloadable PowerPoint Slideset:

Practice in Evolution: Optimal Management of Colorectal Cancer

Explore the optimal clinical management of colorectal cancer through 2 journal article reviews, an expert case discussion, a downloadable slideset, and a video module.

Journal Article Reviews:

CME-Certified Module:

Downloadable PowerPoint Slideset:

CME-Certified Video Module:

Novel Mechanisms of Action in Adjuvant Therapy: Bisphosphonates and Targeted Agents in Solid Tumors

In this new Treatment Update, CCO’s expert faculty members discuss the biological effect of bisphosphonates and their clinical rationale in the adjuvant treatment of breast cancer and other solid tumors.

CME-Certified Modules:

2009 World Conference on Lung Cancer

CME-Certified Conference Report:

Emerging Data in Lung Cancer 2009 Everett Vokes, MD, and Howard (Jack) L. West, MD, discuss the most clinically relevant data from the lung cancer conference in San Francisco, California.

Novel Strategies for Bone-Directed Therapy Across the Cancer Continuum

Downloadable PowerPoint Slideset:

Novel Strategies for Bone-Directed Therapy Across the Cancer Continuum Download slides from the independent symposium presented for attendees of the IX International Meeting on Cancer-Induced Bone Disease by .Allan Lipton, MD; Robert E. Coleman, MD, FRCP; G. David Roodman, MD, PhD; and Matthew R. Smith, MD, PhD on October 29, 2009.

Master Class on Evolving Evidence and Emerging Treatments: Targeted Agents in Advanced Renal Cell Carcinoma

CME-Certified Interactive Virtual Presentation:
Master Class on Evolving Evidence and Emerging Treatments: Targeted Agents in Advanced Renal Cell Carcinoma

Brian I. Rini, MD, discusses current thinking regarding the use of targeted agents in the treatment of kidney cancer.

CCO Slideset:
Master Class on Evolving Evidence and Emerging Treatments: Targeted Agents in Advanced Renal Cell Carcinoma

Download a presentation by Brian I. Rini, MD, in which he recaps the discussions from a Master Class Symposium on current treatment strategies in RCC. Click here to download slides.

2009 American Association for Cancer Research Annual Meeting

CME-Certified Conference Report:

Breakthroughs in Cancer Research 2009 Join Roy S. Herbst, MD, PhD, and Manuel Hidalgo, MD, PhD, as they review clinical implications of breakthroughs in cancer research presented at the 2009 American Association for Cancer Research Annual Meeting.

Practical Applications and Clinical Advances in Multiple Myeloma

Through 2 didactic modules, 3 Interactive Virtual Presentations, and a downloadable slideset, CCO’s expert faculty members explore recent data and clinical considerations that affect outcomes in the setting of multiple myeloma.

CME/CE-Certified Modules:

CME-Certified Interactive Virtual Presentation:

Ovarian Cancer—Recent Developments in the Standard of Care and Emerging Options

Through 3 Interactive Virtual Presentations and associated downloadable slidesets, CCO’s expert faculty members explore current thinking and recent data that are shaping the future of ovarian cancer treatment.

CME-Certified Virtual Presentations:

Downloadable PowerPoint Slidesets:

I. Frontline Management: IP and Maintenance Therapy. II. Rising CA-125: To Treat or Not to Treat? Download slides on IP and maintenance therapy in ovarian cancer and of the role of CA-125 in this disease for use in your noncommercial presentations.

I. Platinum-Resistant Recurrent Disease. II. The Role of Platinum Doublets in Platinum-Sensitive Recurrent Disease Download slides on treatment options in platinum-resistant recurrent ovarian cancer and on the use of platinum doublets in treating patients with platinum-sensitive disease.

I. Platinum-Sensitive Recurrent Ovarian Cancer (Nonplatinum Doublets). II. Platinum-Sensitive Recurrent Disease: Role of Biologics and Secondary Cytoreduction? View slides on recent data on the use of nonplatinum doublets in platinum-sensitive recurrent ovarian cancer and on the roles of biologic agents and secondary cytoreduction in recurrent disease.

2009 Oncology Nursing Society Annual Congress

In this Conference Report, CCO’s expert faculty members review results regarding novel therapies and supportive care strategies presented at the 2009 Oncology Nursing Society Annual Congress.

CME-Certified Conference Report:

Novel Therapies and Supportive Care Carrie Daly, RN, MS, AOCN, and Marilyn Haas, PhD, RN, CNS, ANP-BC, summarize the highlights on novel treatments and supportive care from the 2009 Oncology Nursing Society Congress.

Allogeneic Transplantation: Applying New Research for Improved Outcomes 

In this CME-certified Treatment Update, produced by CCO and the National Marrow Donor Program, CCO’s expert faculty members explore when allogeneic transplantation should be considered, what factors influence outcomes, the effect of age on patient eligibility, and recent advances in HLA matching.

CME-Certified Virtual Presentations:

Comparing Outcomes of Related and Unrelated Transplantations Claudio Anasetti, MD, summarizes research that compares outcomes of related and unrelated donor transplants.

Comparing Outcomes of Related and Unrelated Transplants Download slides in which Claudio Anasetti, MD compares outcomes from related and unrelated HLA-matched allogeneic stem cell transplantation.

Transplantation from Unrelated Donors: Factors That Influence Outcomes and Graft Choices Mary Horowitz, MD, explains the influence of patient and donor factors on unrelated transplant outcomes.

Transplantation from Unrelated Donors: Factors That Influence Outcomes – and Graft Choices Download slides in which Mary Horowitz, MD explains which donor and recipient factors affect outcomes in hematopoietic stem cell transplantations from unrelated donors.

Advances in HLA Matching for Unrelated Donor Transplantation Dennis L. Confer, MD, explains advances in HLA typing including clinical and technology innovations.

Advances in HLA Matching for Unrelated Donor Transplantation Download slides in which Dennis L. Confer, MD, explains the work of the National Marrow Donor Program and describes advances in HLA typing.

Advances in the Management of Bone Health and Skeletal Complications in Cancer

CME/CE-Certified Interactive Virtual Presentations:

Advances in the Management of Bone Health in Multiple Myeloma

James Berenson, MD, presents cases to illustrate key concepts of bone health in cancer patients, particularly those with multiple myeloma. Click here to begin.

Advances in the Management of Bone Health in Prostate Cancer

Matthew R. Smith, MD, PhD, reviews the current standard of care and emerging treatment options for prostate cancer patients at risk for bone disease. Click here to begin.

Bone Health and Skeletal Complications in Breast Cancer

Robert E. Coleman, MD, FRCP, reviews the current standards of care and emerging treatment options for breast cancer patients at risk for bone disease.

CCO Downloadable Slidesets:

Advances in the Management of Bone Health in Multiple Myeloma Review the incidence, pathophysiology, and current management of bone complications in multiple myeloma patients. In addition emerging targeted therapies and their modes of action are discussed. Click here to download slides.

Advances in the Management of Bone Health in Prostate Cancer Review the current standard of care and examine emerging treatment options for prostate cancer patients at risk of bone disease. Click here to download slides.

Bone Health and Skeletal Complications in Breast Cancer Review the current standard of care and examine emerging treatment options for breast cancer patients at risk of skeletal complications and bone metastasis. Click here to download slides.

Highlights of the 12th International Myeloma Workshop: A Video-Based Educational Program

CME-Certified Video Modules:

• Multiple Myeloma: Microenvironment
  Kenneth Anderson, MD, discusses the important data in microenvironment studies presented at the XII International Myeloma Workshop. Click here to begin.
  
  
• Multiple Myeloma: The Role of Transplantation
  Jean-Luc Harousseau, MD, explores the most recent data in treatment approaches for transplantation-eligible myeloma patients. Click here to begin.
  
  
• Multiple Myeloma: Frontline Therapies in Multiple Myeloma
  Sagar Lonial, MD, reviews updates in clinical trials evaluating frontline treatment approaches for both transplantation-eligible and transplantation-ineligible patients. Click here to begin.
  
  
• Multiple Myeloma: Novel Treatment Approaches in Multiple Myeloma
  Robert Z. Orlowski, MD, PhD, explores recent data from trials evaluating novel agents and treatment approaches for treating patients with multiple myeloma. Click here to begin.
  
  
• Multiple Myeloma: Current and Future Perspectives
  Paul G. Richardson, MD, discusses the latest research data and the future directions of therapy in myeloma presented at the XII International Myeloma Workshop. Click here to begin.
  
  
• Multiple Myeloma: Treatment Options in the Nontransplantation Setting
  Jesús F. San Miguel, MD, PhD, reviews the most compelling data from trials evaluating novel approaches in transplantation-ineligible patients presented at the 12th International Myeloma Workshop. Click here to begin.

7th International Symposium on Translational Research in Oncology

CME-Certified Modules:

7th International Symposium on Translational Research in Oncology

Highlights from the 2008 Translational Research meeting.

CCO Downloadable Slideset:

7th International Symposium on Translational Research

Downloadable slideset on highlights in translational research focused on new pathways and drug targets in oncology.

Evolving Treatment Options and Future Directions in Mantle Cell Lymphoma

CME-Certified Modules:

State-of-the-Art First-line Treatment of MCL: Current and Novel Approaches  

Andrew D. Zelenetz, MD, PhD, reviews the latest data on current and novel therapeutic approaches for frontline treatment of mantle cell lymphoma.

Steven H. Bernstein, MD, explores current recommendations and options for the treatment of advanced mantle cell lymphoma and discusses what recent clinical trial results may signify for patients.

The Role of Maintenance Therapy and Individualization of Therapy in Mantle Cell Lymphoma

Sven de Vos, MD, PhD, reviews the current status of maintenance therapy for mantle cell lymphoma and explores new developments in prognostic measures and markers that may lead to the individualization of therapy.

Practical Nursing Management Considerations in Mantle Cell Lymphoma

CCO Downloadable Slideset:

Practical Nursing Management Considerations in Mantle Cell Lymphoma

Download slides on important nursing considerations for patients who are receiving medical therapy for mantle cell lymphoma.

A Call to Action: Preventing Bone Loss and Skeletal-Related Events in Patients With Prostate Cancer: Highlights From the Symposium 

CME-Certified Slideset Module:

A Call to Action: Preventing Bone Loss and Skeletal-Related Events in Patients With Prostate Cancer: Highlights From the Symposium
Expert faculty provide an overview of the bone microenvironment, treatment-related bone loss, prevention of metastatic disease, and evolving treatment options for managing bone health in prostate cancer patients.

A Call to Action: Preventing Bone Loss and Skeletal-Related Events in Patients With Prostate Cancer: Highlights From the Symposium Download slides focused on the mechanisms underlying the bone microenvironment and how to best manage bone health and skeletal-related events in prostate cancer patients.

Current Treatment Options in Acute Lymphoblastic Leukemia

Expert review and Interactive Virtual Presentations on treatment options in acute lymphoblastic leukemia.

CME-Certified Module:

Current Treatment Options in Acute Lymphoblastic Leukemia

Dan Douer, MD, reviews current standards of care for adults and children with ALL and explores changes in the treatment landscape with the potential to improve outcomes.

CME-Certified Interactive Virtual Presentations:

Allogeneic Transplantation for Ph+ Acute Lymphoblastic Leukemia

Jacob M. Rowe, MD, FACP, explores current thinking regarding treatment strategies for adults with acute lymphoblastic leukemia.

ALL in Special Populations: Adolescents/Young Adults and Older Adults

Adele K. Fielding, MB BS, PhD, FRCP, FRCPath, reviews strategies to improve treatment outcomes in 2 special patient populations affected by ALL: young adults and the elderly.

Downloadable PowerPoint Slidesets:

Allogeneic Transplantation for Ph+ Acute Lymphoblastic Leukemia Download a slide presentation by Jacob M. Rowe, MD, FACP, focusing on allogeneic transplantation in patients with Philadelphia chromosome–positive ALL.

ALL in Special Populations: Adolescents/Young Adults and Older Adults Download a presentation by Adele K. Fielding, MB BS, PhD, FRCP, FRCPath, in which she reviews treatment strategies in 2 special patient populations affected by ALL: young adults and the elderly.

2009 American Society of Clinical Oncology Annual Meeting

CCO's independent coverage of the 2009 Clinical Oncology meeting includes Capsule Summaries of key presentations, as well as Expert Analyses, Slides, Expert Recaps, and audio Expert Highlights that focus on key issues highlighted at the conference.

• Breast Cancer
  Robert S. Mocharnuk, MD, William J. Gradishar, MD, FACP, Kathy D. Miller, MD, Mark D. Pegram, MD 
• Colorectal Cancer
  Anthony El-Khoueiry, MD, Edward Chu, MD, Richard M. Goldberg, MD, Alan P. Venook, MD, Anthony El-Khoueiry, MD
• Hematologic Malignancies
  Edward A. Stadtmauer, MD, Kenneth Anderson, MD, Andre Goy, MD, Susan M. O’Brien, MD
• Lung Cancer
  Barbara J. Gitlitz, MD, David R. Gandara, MD, Ramaswamy Govindan, MD, Corey J. Langer, MD, FACP

Integrating Novel Approaches to Therapy Into the Multidisciplinary Treatment of Sarcomas

Suzanne George, MD, reviews current and evolving treatment of sarcoma.

Multidisciplinary Strategies in the Management of Patients With Hepatocellular Carcinoma: A Video Roundtable

Expert faculty members review and explore regional and systemic treatment strategies for the clinical management of patients with hepatocellular carcinoma.

Now Available!

Video Panels:

Hematology

• Advances in Lymphoproliferative Disease: From Molecular Pathogenesis to Multitargeted Treatment
  Through 5 text-based modules, 5 downloadable slidesets, and a debate discussion, CCO's expert faculty members explore current and novel agents used to treat leukemias, lymphomas, and other lymphoproliferative diseases.
  
  
  

Oncology
 

• Expert Guidance in Defining and Treating Castrate-Resistant Prostate Cancer
  David I. Quinn, MD, PhD, explores current approaches for managing patients with castrate-resistant prostate cancer. Nicholas J. Vogelzang, MD, reviews the standards of care and emerging novel therapies for the treatment of castrate-resistant prostate cancer.
  
  
  
• Treatment Paradigms in Recurrent GBM: Today’s Options and Tomorrow’s Promising Directions
  Through 3 Virtual Presentations and associated downloadable slidesets and an audio archive, CCO’s expert faculty members explore current thinking regarding the treatment of glioblastoma.
  
  
  
• Beyond Chemotherapy: Current and Future Molecular-Targeted Therapy in Ovarian Cancer
  Through 4 downloadable slidesets, CCO’s expert faculty members focus on the role of molecular therapies in the treatment of ovarian cancer.
  
  
  
• Bone Health and Skeletal Complications in Cancer: Insights Into Pathogenesis, Advances in Management
  This Treatment Update helps clinicians apply current thinking regarding maintaining and optimizing bone health in cancer patients through 4 CME-certified educational modules.
  
  
  
• Current Research Directions in Glioblastoma Multiforme: Evolutions in Targeted Therapy
  Review expert discussions and a downloadable slideset on GBM.
  
  
  
• Translating Science Into Clinical Practice: Recent Lessons in EGFR Inhibition, Multitargeted TKIs, and the Tumor Microenvironment
  Through 4 CME-certified educational modules and accompanying downloadable slidesets, CCO's expert faculty members explore the use of targeted approaches in the treatment of cancer.
  
  
  
• Improving Survival in Colorectal Cancer Through Optimal Management of Liver Metastases
  These Interactive Case Challenges allow you to consider the appropriate treatment decisions for colorectal cancer patients with liver metastases. Compare your answers with those of other participants and receive expert feedback from the faculty members.
  
  
  
• Cases in Point: Risk Factors, Surveillance Strategies, and Treatment Options for Hepatocellular Carcinoma
  Review monitoring and surveillance recommendations for HCC and emerging strategies for treatment and management, then download slides for use in your own self-study or presentations.
  
  
  
• Managing Ovarian Cancer Recurrence: Coupling Novel Therapeutics With Optimal Treatment Decisions
  This new Treatment Update delivers an overview of current thinking regarding management of recurrent ovarian cancer through 3 CME-certified educational modules and a downloadable slideset. 
  
  

• 2009 American Society of Clinical Oncology Annual Meeting*
   
  
• 2009 Gastrointestinal Cancers Symposium*
  
  
• 2008 Annual Meeting of the European Society for Medical Oncology* 
  
  
• 2008 Chicago Multidisciplinary Symposium in Thoracic Oncology*
   
  
• 2008 San Antonio Breast Cancer Symposium*
  
  
• 2008 American Society of Hematology Annual Meeting*
  
  
• 2008 International Symposium on Supportive Care in Cancer*
  
  
  
  

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

Quickly access answers to your point-of-care questions

LATEST UPDATES:

Metastatic Non-Small-Cell Lung Cancer: Updated to reflect ASCO clinical practice guideline updates for chemotherapy for stage IV NSCLC. 

Nonmelanoma Skin Cancers: Updated to include romidepsin, a newly FDA-approved systemic treatment for relapsed/refractory cutaneous T-cell lymphoma.

Topics

• Breast Cancer
• Colorectal Cancer
• Gastrointestinal Cancer
• Genitourinary Cancer
• Glioblastoma
• Gynecologic Cancer
• Head and Neck Cancer
• Hematologic Malignancies
• Hepatocellular Cancer
• Leukemias 
• Lung Cancer
• Lymphomas
• Melanoma and Other Skin Cancers
• Multiple Myeloma
• Oncology Nursing
• Other Oncology Topics
• Ovarian Cancer
• Pancreatic Cancer
• Prostate Cancer
• Renal Cell Carcinoma
• Research Updates
• Supportive Care

Resources

• Advanced Search
• Case Challenges
• Live Events
• Slide Download Library
• Free Bookstore
• CCO inPractice

This resource has been specific designed to meet the educational needs of oncology nurses. Check regularly for the latest conference coverage, treatment updates and plenty of free CE hours. Click here.

FEATURED VIDEO SEGMENT
Expert Highlight: ESAs in Cancer

David P. Steensma, MD, describes a patient-level meta-analysis on the effect of ESAs on the survival of cancer patients and the implications for patient care. Click here.

Evaluation of Ki67 Soon After Start of Neoadjuvant AI Identifies Breast Cancer Patients Likely to Have Poor Outcomes

The findings of this retrospective analysis suggest that some patients may benefit from an early switch to chemotherapy prior to surgery.

Click here for related capsule summaries

Click here for the more slides.

Click here for more cases.